Cargando…
TOP2A correlates with poor prognosis and affects radioresistance of medulloblastoma
Radiotherapy remains the standard treatment for medulloblastoma (MB), and the radioresistance contributes to tumor recurrence and poor clinical outcomes. Nuclear DNA topoisomerase II-alpha (TOP2A) is a key catalytic enzyme that initiates DNA replication, and studies have shown that TOP2A is closely...
Autores principales: | Zhang, Yufeng, Yang, Haiyan, Wang, Liwen, Zhou, Huandi, Zhang, Ge, Xiao, Zhiqing, Xue, Xiaoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337862/ https://www.ncbi.nlm.nih.gov/pubmed/35912241 http://dx.doi.org/10.3389/fonc.2022.918959 |
Ejemplares similares
-
A molecular view of the radioresistance of gliomas
por: Han, Xuetao, et al.
Publicado: (2017) -
Tumor-Associated Macrophages Correlate With Prognosis in Medulloblastoma
por: Zhang, Jin, et al.
Publicado: (2022) -
Loss of 5-Hydroxymethylcytosine as an Epigenetic Signature That Correlates With Poor Outcomes in Patients With Medulloblastoma
por: Zhao, Fu, et al.
Publicado: (2021) -
Molecular Interplays Between Cell Invasion and Radioresistance That Lead to Poor Prognosis in Head-Neck Cancer
por: You, Guo-Rung, et al.
Publicado: (2021) -
NRAGE Confers Radiation Resistance in 2D and 3D Cell Culture and Poor Outcome in Patients With Esophageal Squamous Cell Carcinoma
por: Zhou, Huandi, et al.
Publicado: (2022)